Show simple item record

dc.contributor.authorTennyson, Sharon
dc.date.accessioned2010-06-11T13:45:18Z
dc.date.available2010-06-11T13:45:18Z
dc.date.issued2009
dc.identifier.citationRisk Management and Insurance Review Vol. 12 No. 1 Winter 2009: 37-64en_US
dc.identifier.urihttps://hdl.handle.net/1813/15116
dc.description.abstractWe present the first systematic analysis of state policies limiting prescription drug access under Medicaid during 1990–2004, documenting their impact on states’Medicaid prescription spending growth.We see substantial variation in the number and type of policies used by states, but a clear upward trend in restrictions over time. Analysis of state level annual spending growth shows that these restrictions have in general helped contain Medicaid prescription drug costs and that some approaches, such as the use of preferred drug lists (PDLs) and tiered copayment systems, may have been more effective than others.en_US
dc.language.isoen_USen_US
dc.subjectPolicy Analysis and Managementen_US
dc.titleDo State Cost Control Policies Reduce Medicaid Prescription Drug Spending?en_US
dc.typearticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics